ATE398137T1 - Porphyromonas gingivalis antigene zur diagnose und behandlung von periodontitis - Google Patents

Porphyromonas gingivalis antigene zur diagnose und behandlung von periodontitis

Info

Publication number
ATE398137T1
ATE398137T1 AT97913999T AT97913999T ATE398137T1 AT E398137 T1 ATE398137 T1 AT E398137T1 AT 97913999 T AT97913999 T AT 97913999T AT 97913999 T AT97913999 T AT 97913999T AT E398137 T1 ATE398137 T1 AT E398137T1
Authority
AT
Austria
Prior art keywords
antigen
gingivalis
amino acid
acid sequence
internal amino
Prior art date
Application number
AT97913999T
Other languages
English (en)
Inventor
Eric Reynolds
Nada Slakeski
Anne Hendtlass
Original Assignee
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Melbourne filed Critical Univ Melbourne
Application granted granted Critical
Publication of ATE398137T1 publication Critical patent/ATE398137T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Wood Science & Technology (AREA)
AT97913999T 1996-03-29 1997-04-01 Porphyromonas gingivalis antigene zur diagnose und behandlung von periodontitis ATE398137T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN9012A AUPN901296A0 (en) 1996-03-29 1996-03-29 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis

Publications (1)

Publication Number Publication Date
ATE398137T1 true ATE398137T1 (de) 2008-07-15

Family

ID=3793326

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97913999T ATE398137T1 (de) 1996-03-29 1997-04-01 Porphyromonas gingivalis antigene zur diagnose und behandlung von periodontitis

Country Status (12)

Country Link
US (1) US6528038B1 (de)
EP (1) EP0954529B1 (de)
JP (1) JP4358909B2 (de)
KR (1) KR100527070B1 (de)
AT (1) ATE398137T1 (de)
AU (1) AUPN901296A0 (de)
CA (1) CA2249746C (de)
DE (1) DE69738770D1 (de)
DK (1) DK0954529T3 (de)
NZ (1) NZ331557A (de)
WO (1) WO1997036923A1 (de)
ZA (1) ZA972757B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO652897A0 (en) 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
US8129500B2 (en) * 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
KR100603552B1 (ko) * 1997-12-10 2006-07-20 씨에스엘 리미티드 포피로모나스 긴기발리스 폴리펩티드 및 뉴클레오티드
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
AUPP893999A0 (en) * 1999-03-01 1999-03-25 Csl Limited Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
DE60126768T2 (de) * 2000-06-16 2007-10-25 Baylor Research Institute, Dallas ADJUVANTIEN UND VERFAHREN ZUR INDUKTION EINER Th2 IMMUNANTWORT
JP5469785B2 (ja) * 2004-02-06 2014-04-16 有限会社 ミクロデント ポルフィロモナスジンジバリス試薬
US7838259B2 (en) 2005-02-01 2010-11-23 University Of Florida Research Foundation Genes of Porphyromonas gingivalis W83 involved in invasion of human cells
US20100092471A1 (en) * 2006-06-27 2010-04-15 Oral Health Australia Pty Ltd Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease
NZ595378A (en) 2007-07-12 2013-04-26 Immunology treatment for biofilms
ES2714008T3 (es) 2007-07-12 2019-05-24 Oral Health Australia Pty Ltd Tratamiento de biopelícula
NZ598834A (en) 2008-08-29 2013-06-28 Oral Health Australia Pty Ltd Prevention, treatment and diagnosis of P. gingivalis infection
CN102712693A (zh) * 2009-08-02 2012-10-03 圣诺菲·帕斯图尔有限公司 牙龈卟啉单胞菌多肽
US8140041B2 (en) * 2009-08-27 2012-03-20 Mediatek Inc. Tunable capacitive device with linearization technique employed therein
KR102037969B1 (ko) * 2019-07-25 2019-10-29 주식회사 하이센스바이오 신규한 펩타이드

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60142915A (ja) * 1983-12-28 1985-07-29 Lion Corp 口腔用組成物
CA1282691C (en) * 1986-02-26 1991-04-09 Robert Joseph Genco Monoclonal antibodies useful in the identification of microorganisms causing periodontal disease
US5830710A (en) * 1988-09-08 1998-11-03 University Of Florida Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
US5399484A (en) * 1991-10-08 1995-03-21 Eastman Kodak Company Use of blocking protein with high pH extraction in method to determine a microorganism associated with periodontal disease and kit useful therefor
US5523390A (en) * 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
JPH0797395A (ja) * 1993-09-28 1995-04-11 Kyowa Medex Co Ltd ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途
AU7822394A (en) * 1993-10-08 1995-05-04 Lion Corporation Fimbrillin protein of porphyromonas gingivalis
WO1995026404A1 (fr) * 1994-03-29 1995-10-05 Kyowa Hakko Kogyo Co., Ltd. Gene de polypeptide de surface

Also Published As

Publication number Publication date
JP2001501808A (ja) 2001-02-13
ZA972757B (en) 1998-01-30
CA2249746A1 (en) 1997-10-09
EP0954529A4 (de) 2003-02-05
EP0954529B1 (de) 2008-06-11
NZ331557A (en) 1999-11-29
KR19990087436A (ko) 1999-12-27
DE69738770D1 (de) 2008-07-24
JP4358909B2 (ja) 2009-11-04
DK0954529T3 (da) 2008-09-29
CA2249746C (en) 2012-06-12
KR100527070B1 (ko) 2006-06-29
EP0954529A1 (de) 1999-11-10
WO1997036923A1 (en) 1997-10-09
US6528038B1 (en) 2003-03-04
AUPN901296A0 (en) 1996-04-26

Similar Documents

Publication Publication Date Title
ATE398137T1 (de) Porphyromonas gingivalis antigene zur diagnose und behandlung von periodontitis
DE69129302T2 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
ES8801318A1 (es) Un procedimiento para la produccion de un peptido.
DE69316948D1 (de) Lösliche Liganden für CD40
ATE262348T1 (de) Mittel zur verabreichung von antigenen
TR199801722T2 (xx) Peptit imm�nojenler.
ATE141286T1 (de) Hiv-peptide, künstliche hiv-antigene und immuntestsätze
FI964845A0 (fi) CD44v6:n vastaiset monoklonaaliset vasta-aineet
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
BG102541A (en) Diagnostics and mediators of inflammatory processes
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
CA2639048A1 (en) Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
DE69527986D1 (de) Antigene arznei zur behandlung oder vorbeugung
AU612683B2 (en) Synthetic peptides, antibodies directed against them, and the use thereof
GB9501826D0 (en) Polypeptide fragments
DE3885365T2 (de) Spezifische Sekretions-Exkretions-Antigene von Toxoplasma gondii, deren Expressionsprodukte, Verfahren zu deren Herstellung und deren diagnostische und prophylaktische Anwendungen.
JPS5615215A (en) Preparation of human immunoglobulin for intravenous injection with immobilized pepsin gel
ZA9601216D (en) Novel Antigen.
FR2559157B1 (fr) Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
CA2165672A1 (en) Antibodies specific for human prostate glandular kallikrein

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties